By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sankyo Company, Ltd. 

3-5-1, Nihonbashi Hon-Cho

Chuo-ku  Tokyo  103-8426  Japan
Phone: 03-5255-7111 Fax:


Medical Device

Company News
Hovione Licenses Inhaler Technology for Influenza Drug to Sankyo Company, Ltd. (SKXOF.PK) and Biota Holdings Limited (BTA.AX) 3/5/2007 12:22:01 PM
Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection 10/2/2006 10:21:00 AM
Ajinomoto And Sankyo Company, Ltd. (SKXOF.PK) In Joint Development, Manufacture And Marketing Of AJD101, New Diabetes Drug 8/31/2006 9:40:59 AM
Sankyo Company, Ltd. (SKXOF.PK) To Manufacture, Distribute Olmetic Antihypertensive Drug In China 8/14/2006 1:35:25 PM
Sankyo To Manufacture, Distribute Olmetic Antihypertensive Drug In China 8/4/2006 5:51:40 PM
Sankyo Company, Ltd. (SKXOF.PK) To Launch Osteoporosis Treatment Drug In Europe 7/19/2006 2:19:19 PM
Sankyo Company, Ltd. (SKXOF.PK) Selected Evotec OAI (Germany) (EVTG.F) As Assay Development And Screening Partner 4/27/2006 10:28:30 AM
Exelixis, Inc. (EXEL) And Sankyo Company, Ltd. (SKXOF.PK) Sign Collaboration Agreement To Develop Novel Therapies For Cardiovascular Disease; $20 Million Upfront Payment 3/20/2006 10:35:46 AM
MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies 3/16/2006 12:39:34 PM
Eli Lilly and Company (LLY) And Sankyo Company, Ltd. (SKXOF.PK) Release: Study Shows More Potent And More Reliable Platelet Inhibition wWth Prasugrel Compared To Clopidogrel Even In Patients With More Reactive Platelets 3/14/2006 2:33:55 PM